BENEVICH ERIC
Chief Commercial Officer
BENEVICH ERIC has filed 6 SEC Form 4 filings (17 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.
On the most recent filing, BENEVICH ERIC is listed as Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC. Inside the rolling window, BENEVICH ERIC reported no open-market purchases and 2 open-market sales totaling $1.2M in NBIX. The largest disclosed transaction in the window is a sale of 5,970 NBIX shares on Nov 28, 2025, worth $906K.
Companies traded
Other insiders at NBIX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BENEVICH ERIC made?
BENEVICH ERIC has filed 6 SEC Form 4 filings (17 transaction rows) across 1 company since 2025.
Which companies does BENEVICH ERIC trade?
BENEVICH ERIC has filed SEC Form 4 disclosures for 1 company, including NBIX.
When was BENEVICH ERIC's most recent SEC Form 4 filing?
BENEVICH ERIC's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.
What is BENEVICH ERIC's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, BENEVICH ERIC is listed as Chief Commercial Officer.
What is BENEVICH ERIC's total buy and sell value in the current window?
Inside the rolling retention window, BENEVICH ERIC bought $0 and sold $1.2M based on SEC Form 4 filings.
What was BENEVICH ERIC's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,970 NBIX shares on 2025-11-28, worth $906K, per SEC Form 4 filings.